Suppr超能文献

笑疗对癌症患者生活质量的影响:一项开放标签、随机对照试验。

Effects of laughter therapy on quality of life in patients with cancer: An open-label, randomized controlled trial.

机构信息

Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.

Department of Tumor Immunology, Research Center, Osaka International Cancer Institute, Osaka, Japan.

出版信息

PLoS One. 2019 Jun 27;14(6):e0219065. doi: 10.1371/journal.pone.0219065. eCollection 2019.

Abstract

BACKGROUND

Few randomized controlled trials have assessed the effects of laughter therapy on health-related quality of life (QOL) in cancer patients. This study aimed to evaluate these effects as an exploratory endpoint in cancer patients as part of a randomized controlled trial conducted at a single institution in Japan.

METHODS

The Initiative On Smile And CAncer (iOSACA) study was an open-label randomized controlled trial conducted in 2017 in which participants aged 40-64 years with cancer were randomly assigned to either an intervention group (laughter therapy) or control group (no laughter therapy). Each participant in the intervention group underwent a laughter therapy session once every two weeks for seven weeks (total of four sessions). Each session involved a laughter yoga routine followed by Rakugo or Manzai traditional Japanese verbal comedy performances. We assessed QOL as a secondary endpoint in this intention-to-treat population using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). The questionnaire was completed at baseline (Week 0) and at Weeks 3 and 7. Mixed-effects models for repeated measures were developed to compare time-dependent changes in each QOL domain from baseline between the intervention and control groups.

RESULTS

Four participants retracted consent and one participant was retrospectively excluded from analysis due to unmet inclusion criteria. The analysis was conducted using 56 participants, with 26 in the intervention group and 30 in the control group. Questionnaire completion rates were high (>90%), with similar QOL scores reported at baseline in both groups. The mixed-effects models showed that the intervention group had significantly better cognitive function and less pain than the control group for a short period.

CONCLUSION

Laughter therapy may represent a beneficial, noninvasive complementary intervention in the clinical setting. Further studies are needed to verify the hypotheses generated from this exploratory study.

摘要

背景

很少有随机对照试验评估过笑疗对癌症患者健康相关生活质量(QOL)的影响。本研究旨在评估笑疗对癌症患者的这些影响,作为在日本一家机构进行的随机对照试验的探索性终点。

方法

微笑与癌症倡议(iOSACA)研究是一项 2017 年进行的开放性随机对照试验,纳入年龄在 40-64 岁之间的癌症患者,随机分为干预组(笑疗)和对照组(无笑疗)。干预组的每位患者每两周接受一次笑疗,共进行七周(共四次)。每次笑疗包括笑瑜伽练习,随后是日本传统的落语或漫才喜剧表演。我们采用欧洲癌症研究与治疗组织生活质量问卷核心 30 版(EORTC QLQ-C30)作为意向治疗人群的次要终点评估生活质量。该问卷在基线(第 0 周)和第 3 周和第 7 周进行。为比较干预组和对照组之间从基线开始每个 QOL 领域的时间依赖性变化,建立了重复测量混合效应模型。

结果

四名参与者撤回同意,一名参与者因未满足纳入标准而被回顾性排除分析。对 56 名参与者进行了分析,其中干预组 26 人,对照组 30 人。问卷完成率很高(>90%),两组基线 QOL 评分相似。混合效应模型显示,在短时间内,干预组的认知功能明显优于对照组,疼痛程度明显低于对照组。

结论

笑疗可能是一种有益的、非侵入性的临床补充干预措施。需要进一步的研究来验证本探索性研究提出的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f77/6597115/b792607381a9/pone.0219065.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验